Evidence map›Paper›PMID 28576596›Full record

ArticleThe Journal of infection2017

Bronchoalveolar lavage triacetylfusarinine C (TAFC) determination for diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies.

Thomas Orasch, Juergen Prattes, Klaus Faserl, Susanne Eigl, Wiebke Düttmann, Herbert Lindner, Hubertus Haas, Martin Hoenigl

Registry-linked trialAbstract readLetterComment
In one paragraph

Article in The Journal of infection, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05860387 (Early Diagnosis of Invasive Lung Aspergillosis), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05860387 recruitingnot on this mapstarted 2023, after this paper: background citation

Early Diagnosis of Invasive Lung Aspergillosis

TypeobservationalSponsorUniversity Hospital OstravaRan2023 to 2026Enrolled150ConditionsRespiratory Infection, Invasive Pulmonary AspergillosisArmsNext generation improvement of early invasive aspergillosis
3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Current and Future Pathways inAntibiotics (Basel, Switzerland) · 2023
    Review
  5. Article
  6. Article
  7. Studies in mycology · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Treatment of Aspergillosis.Journal of fungi (Basel, Switzerland) · 2018
    Review
  12. Review
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Thomas OraschDivision of Molecular Biology, Innsbruck Medical University, Innsbruck, Austria.
Juergen PrattesSection of Infectious Diseases and Tropical Medicine, Medical University of Graz, Graz, Austria; CBmed Center for Biomarker Research in Medicine, Graz, Austria.
Klaus FaserlDivision of Clinical Biochemistry, Innsbruck Medical University, Innsbruck, Austria.
Susanne EiglDivision of Pulmonology, Medical University of Graz, Graz, Austria.
Wiebke DüttmannSection of Infectious Diseases and Tropical Medicine, Medical University of Graz, Graz, Austria.
Herbert LindnerDivision of Clinical Biochemistry, Innsbruck Medical University, Innsbruck, Austria.
Hubertus HaasDivision of Molecular Biology, Innsbruck Medical University, Innsbruck, Austria. Electronic address: hubertus.haas@i-med.ac.at.
Martin HoeniglSection of Infectious Diseases and Tropical Medicine, Medical University of Graz, Graz, Austria; CBmed Center for Biomarker Research in Medicine, Graz, Austria; Division of Pulmonology, Medical University of Graz, Graz, Austria; Division of Infectious Diseases, Department of Medicine, University of California San Diego, San Diego, CA, USA. Electronic address: martin.hoenigl@medunigraz.at.

Funding

Austrian Science Fund FWF W 1253
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bronchoalveolar LavageInvasive Pulmonary AspergillosisAspergillosisBronchoalveolar Lavage FluidFerric CompoundsHematologic NeoplasmsHumansHydroxamic AcidsMannansSensitivity and SpecificityFerric CompoundsHydroxamic AcidsMannansN,N',N''-triacetylfusarinine CAntifungal prophylaxisAntimould treatmentGalactomannanLateral flow deviceSiderophores

Identifiers

PMID28576596
PMCPMC5757784

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.